LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset (ID:20247)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BT-20 | Mitoxantrone | 0.12 | uM | LJP5 | 2 | C23 | 72 | hr | 1097 | 1102 | 3877 | 0.2842 | 0.0024 |
BT-20 | Mitoxantrone | 0.12 | uM | LJP5 | 3 | C23 | 72 | hr | 1097 | 1280 | 3925 | 0.3261 | 0.0874 |
BT-20 | Mitoxantrone | 0.37 | uM | LJP6 | 1 | C22 | 72 | hr | 1097 | 1084 | 3610 | 0.3002 | -0.0070 |
BT-20 | Mitoxantrone | 0.37 | uM | LJP6 | 2 | C22 | 72 | hr | 1097 | 973 | 3713 | 0.2620 | -0.0660 |
BT-20 | Mitoxantrone | 0.37 | uM | LJP6 | 3 | C22 | 72 | hr | 1097 | 926 | 3696 | 0.2505 | -0.0923 |
BT-20 | Mitoxantrone | 0.37 | uM | LJP5 | 1 | C22 | 72 | hr | 1097 | 883 | 3735 | 0.2364 | -0.1157 |
BT-20 | Mitoxantrone | 0.37 | uM | LJP5 | 2 | C22 | 72 | hr | 1097 | 912 | 3877 | 0.2352 | -0.0965 |
BT-20 | Mitoxantrone | 0.37 | uM | LJP5 | 3 | C22 | 72 | hr | 1097 | 956 | 3925 | 0.2435 | -0.0722 |
BT-20 | Mitoxantrone | 1.11 | uM | LJP6 | 1 | C21 | 72 | hr | 1097 | 860 | 3610 | 0.2382 | -0.1322 |
BT-20 | Mitoxantrone | 1.11 | uM | LJP6 | 2 | C21 | 72 | hr | 1097 | 682 | 3713 | 0.1836 | -0.2369 |
BT-20 | Mitoxantrone | 1.11 | uM | LJP6 | 3 | C21 | 72 | hr | 1097 | 826 | 3696 | 0.2235 | -0.1496 |
BT-20 | Mitoxantrone | 1.11 | uM | LJP5 | 1 | C21 | 72 | hr | 1097 | 851 | 3735 | 0.2278 | -0.1340 |
BT-20 | Mitoxantrone | 1.11 | uM | LJP5 | 2 | C21 | 72 | hr | 1097 | 800 | 3877 | 0.2063 | -0.1593 |
BT-20 | Mitoxantrone | 1.11 | uM | LJP5 | 3 | C21 | 72 | hr | 1097 | 728 | 3925 | 0.1855 | -0.2000 |
BT-20 | Mitoxantrone | 3.33 | uM | LJP6 | 1 | C20 | 72 | hr | 1097 | 753 | 3610 | 0.2086 | -0.1968 |
BT-20 | Mitoxantrone | 3.33 | uM | LJP6 | 2 | C20 | 72 | hr | 1097 | 621 | 3713 | 0.1672 | -0.2765 |
BT-20 | Mitoxantrone | 3.33 | uM | LJP6 | 3 | C20 | 72 | hr | 1097 | 599 | 3696 | 0.1621 | -0.2921 |
BT-20 | Mitoxantrone | 3.33 | uM | LJP5 | 1 | C20 | 72 | hr | 1097 | 665 | 3735 | 0.1780 | -0.2468 |
BT-20 | Mitoxantrone | 3.33 | uM | LJP5 | 2 | C20 | 72 | hr | 1097 | 777 | 3877 | 0.2004 | -0.1726 |
BT-20 | Mitoxantrone | 3.33 | uM | LJP5 | 3 | C20 | 72 | hr | 1097 | 632 | 3925 | 0.1610 | -0.2592 |
BT-20 | Mitoxantrone | 10 | uM | LJP6 | 1 | C19 | 72 | hr | 1097 | 224 | 3610 | 0.0620 | -0.6034 |
BT-20 | Mitoxantrone | 10 | uM | LJP6 | 2 | C19 | 72 | hr | 1097 | 194 | 3713 | 0.0522 | -0.6266 |
BT-20 | Mitoxantrone | 10 | uM | LJP6 | 3 | C19 | 72 | hr | 1097 | 187 | 3696 | 0.0506 | -0.6357 |
BT-20 | Mitoxantrone | 10 | uM | LJP5 | 1 | C19 | 72 | hr | 1097 | 168 | 3735 | 0.0450 | -0.6542 |
BT-20 | Mitoxantrone | 10 | uM | LJP5 | 2 | C19 | 72 | hr | 1097 | 124 | 3877 | 0.0320 | -0.6979 |